Private Management Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Private Management Group’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-831,871	Closed	-$15.5M	–	184
2022 Q1	$15.5M	Buy	831,871 +661,022	+387%	+$11.9M	0.63%	70
2021 Q4	$3.65M	Buy	+170,849	New	+$3.37M	0.15%	99

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Private Management Group's OCDX Position: Q2 2022 in Review

Private Management Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 831,871 shares — an estimated $15.5M sold.

Private Management Group first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $15.5M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Private Management Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Private Management Group sold 831,871 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $15.5M.
Private Management Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
Private Management Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $15.5M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Private Management Group's 13F filing for Q2 2022, filed 5 Aug 2022.